Sensei Biotherapeutics (STU:407) Dividends per Share : €0.00 (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Sensei Biotherapeutics Dividends per Share?

Sensei Biotherapeutics's dividends per share for the three months ended in Sep. 2024 was €0.00. Its dividends per share for the trailing twelve months (TTM) ended in Sep. 2024 was €0.00. Its Dividend Payout Ratio for the three months ended in Sep. 2024 was 0.00. As of today, Sensei Biotherapeutics's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Sensei Biotherapeutics Dividends per Share Historical Data

The historical data trend for Sensei Biotherapeutics's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sensei Biotherapeutics Dividends per Share Chart

Sensei Biotherapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividends per Share

Get a 7-Day Free Trial

Sensei Biotherapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Sensei Biotherapeutics's Dividends per Share

For the Biotechnology subindustry, Sensei Biotherapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sensei Biotherapeutics's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sensei Biotherapeutics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Sensei Biotherapeutics's Dividend Yield % falls into.

Sensei Biotherapeutics Dividends per Share Calculation

Dividends paid to per common share.

Sensei Biotherapeutics (STU:407) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Sensei Biotherapeutics's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Sep. 2024 )	/	EPS without NRI (Q: Sep. 2024 )
	=	0	/	-0.261
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Sensei Biotherapeutics Dividends per Share Related Terms

Thank you for viewing the detailed overview of Sensei Biotherapeutics's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Sensei Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sensei Biotherapeutics Inc (STU:407) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

SNSE:USA

Address

1405 Research Boulevard, Suite 125, Rockville, MD, USA, 20850

Website

https://www.senseibio.com

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.

Sensei Biotherapeutics Headlines

No Headlines